Reference Laboratory

Please select the first letter of the test you are interested in viewing or
click NEW for a complete listing of our newest assays.


	Enter Test Name(s) / Code(s):	Test Title	Description	Category Search:


All words must appear Any word can appear

Reference Laboratory
Tests

51194

AFB Susceptibility, M. tuberculosis Complex Panel, Agar Method (PZA Broth Method)

This test is a comprehensive susceptibility panel that includes both primary and secondary antimicrobial agents to the M. tuberculosis complex. The test is performed by the agar proportion method and includes antimicrobial agents:

Panel includes:

Amikacin, Capreomycin, Ciprofloxacin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, p-Aminosalicylic Acid, Pyrazinamide, Rifampin and Streptomycin.

In order to perform susceptibility testing to the drugs of choice and to interpret test results, the identification of the isolate is required.

This test is available for New York patient testing.

Please see the following technical sheet for more information:

Antimicrobial Testing

Methodology		Agar Dilution, PZA Broth Method
Reference Range		By report
Preferred Specimen		Pure culture safely contained.
Transport Temperature		2-28° C
Results Available		14 to 28 days
CPT Code		87190 x 11

First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics

FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics� Focus Diagnostics

Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.

Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services

Focus Diagnostics Launches Laboratory Test for Chikungunya Virus

Back to top